BioAge Labs Inc (NASDAQ:BIOA) currently has a daily average trading volume of 248.57K but it saw 1711737 shares traded in last market. With a market cap of 153.08M USD, the company’s current market price of $4.27 came rising about 7.02 while comparing to the previous closing price of $3.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.62 and as low as $2.88.
Morgan Stanley downgraded its recommendation for the stock as a “Underweight” from “Overweight” on December 10, 2024 while assigning a price target range of $40-$5. Jefferies issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $42 and $7.
Over the week, BIOA’s stock price is moving 7.29% up while it is 2.89% when we observe its performance for the past one month. Year-to-date it is -26.25% down and over the past year.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of -0.38 while estimate for next year EPS is -1.52. In next quarter, company is expected to be making quarterly sales of $580k as analysts are expecting the sales for current fiscal year at $2.77M and seeing the company making $2.23M in sales next year. Moreover, analysts are in estimates of $580k for current-quarter revenue.
Currently, BioAge Labs Inc’s total number of outstanding shares is 35.85M with 3.63% of that held by the insiders while 66.65% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -22.43% and return on equity (ROE) at -30.20%. Stock has a price to book (P/B) ratio of 0.49 while price to sale or P/S ratio amounts to 105.57. Its return on asset (ROA) is -27.15% on average.
